Results 221 to 230 of about 1,610,408 (351)

The alarmin tandem: unraveling the complex effect of S100A8/A9 - from atherosclerosis to cardiac arrhythmias. [PDF]

Front Immunol
Cozac DA, Halațiu VB, Scridon A.
europepmc   +1 more source

Sex Differences in Cardiac Arrhythmias: Clinical and Research Implications

Circulation: Arrhythmia and Electrophysiology, 2018
Ashkan Ehdaie, E. Cingolani, Michael Shehata, Xunzhang Wang, A. Curtis, S. Chugh   +5 more
semanticscholar   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Cardiac arrhythmias in cancer patients using the nationwide claim-based database in Japan. [PDF]

J Arrhythm
Kobayashi T, Kusano K.
europepmc   +1 more source

Current role of catheter ablative procedures in patients with cardiac arrhythmias. A report for health professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. [PDF]

, 1991
Melvin M. Scheinman, Michael M. Laks, John Dimarco, Vance J. Plumb   +3 more
openalex   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Theory and practice of present clinical use of Quinidine in the management of cardiac arrhythmias. [PDF]

Indian Pacing Electrophysiol J
Belhassen B, Milman A.
europepmc   +1 more source

Accompanying code for " Monitoring pump parameters to detect cardiac arrhythmia and major bleeding in LVAD patients: A proof-of-concept"

, 2023
Mehran Moazeni, Lieke Numan, Maruis K. Szymanski, Deleted Author ID, Folkert W. Asselbergs, Deleted Author ID, Linda W. van Laake, Emmeke Aarts   +7 more
openalex   +2 more sources

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

ESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Inflammatory cytokines and cardiac arrhythmias: from pathogenesis to potential therapies. [PDF]

Ann Med Surg (Lond)
Obeagu EI.
europepmc   +1 more source